Capital Guardian Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-265
Closed -$50K 501
2018
Q3
$50K Buy
+265
New +$48.7K ﹤0.01% 344
2017
Q1
Sell
-302
Closed -$63K 711
2016
Q4
$63K Buy
+302
New +$62.6K ﹤0.01% 432

Other funds holding AGN

Capital Guardian Trust's AGN Position: Q4 2018 in Review

Capital Guardian Trust sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 265 shares — an estimated $50K sold.

Capital Guardian Trust first reported a position in AGN in Q4 2016 and held it in 2 quarters. The position peaked at $63K in Q4 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Capital Guardian Trust reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Capital Guardian Trust sold 265 Allergan plc shares in Q4 2018, an estimated $50K.
  • Capital Guardian Trust first reported a position in Allergan plc in Q4 2016 and held it in 2 quarters.
  • Capital Guardian Trust's Allergan plc position peaked at $63K in Q4 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.